Abstract: The present application is directed to immunomodulatory compositions comprising invariant NKT cell (iNKT cell) agonist compounds that induce expansion of tissue resident memory T-cells (Trm Cells) in combination with an immune stimulator agent that enhances an immune response to a target antigen or a polynucleotide encoding the immune stimulator. The iNKT agonists are ?-GalCer analogue compounds modified at the 6 position of the galactose ring. The immune stimulator is an antigen or an mRNA encoding an antigen to create a vaccine formulation. These combinations are used in the treatment of infection or cancer in a subject, or to enrich the number of Trm cells in the liver of a subject.

Abstract: The invention provides seed and plants of tomato hybrid DR4299TC and the parent lines thereof. The invention thus relates to the plants, seeds and tissue cultures of tomato hybrid DR4299TC and the parent lines thereof, and to methods for producing a tomato plant produced by crossing such plants with themselves or with another tomato plant, such as a plant of another genotype. The invention further relates to seeds and plants produced by such crossing. The invention further relates to parts of such plants, including the fruit and gametes of such plants.

Abstract: The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects.

Abstract: The invention provides seed and plants of tomato hybrid DR4299TC and the parent lines thereof. The invention thus relates to the plants, seeds and tissue cultures of tomato hybrid DR4299TC and the parent lines thereof, and to methods for producing a tomato plant produced by crossing such plants with themselves or with another tomato plant, such as a plant of another genotype. The invention further relates to seeds and plants produced by such crossing. The invention further relates to parts of such plants, including the fruit and gametes of such plants.

Abstract: The invention provides seed and plants of tomato line CHD-A808019. The invention thus relates to the plants, seeds and tissue cultures of tomato line CHD-A808019, and to methods for producing a tomato plant produced by crossing such plants with themselves or with another tomato plant, such as a plant of another genotype. The invention further relates to seeds and plants produced by such crossing. The invention further relates to parts of such plants, including the fruit and gametes of such plants.

Abstract: The invention provides seed and plants of tomato hybrid SV1240TC and the parent lines thereof. The invention thus relates to the plants, seeds and tissue cultures of tomato hybrid SV1240TC and the parent lines thereof, and to methods for producing a tomato plant produced by crossing such plants with themselves or with another tomato plant, such as a plant of another genotype. The invention further relates to seeds and plants produced by such crossing. The invention further relates to parts of such plants, including the fruit and gametes of such plants.

Abstract: The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects.

Abstract: The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects.

Abstract: The present loading dock rainshield has a self-adjusting, weighted canopy seal with a header projecting from the building to support a flexible, dual fixed-end, downwardly looped, central curtain. The central curtain spans the dominant width of the header and loops from front to back. The center curtain joins with opposed pleated side curtains to compete the front seal. The downwardly looped central curtain has a series of staggered and overlapping weighted baffles proximal its front end. When a trailer backs into the dock, the trailer top engages one or more baffles, which ride up onto the top of the trailer. The elongated weighted baffles push rainwater off the trailer top as it backs into the bay, and remain in forced sealing engagement with the trailer top when it is parked to divert water off the trailer top and prevent the water from flowing or blowing into the bay.

Abstract: The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects.

Abstract: Elastomers are prepared from a reaction mixture that contains a polyene compound, an epoxy resin, a thiol curing agent and a basic catalyst. The polyene compound has an average of at least two groups containing aliphatic carbon-carbon double bonds capable of reaction with a thiol group. At least one of said aliphatic carbon-carbon double bonds is separated from each other said aliphatic carbon-carbon double bond by an aliphatic spacer group having a weight of at least 500 atomic mass units. These elastomers are typically phase-separated materials having good elongation and tensile properties.

Abstract: The present loading dock rainshield has a self-adjusting, weighted canopy seal with a header projecting from the building to support a flexible, dual fixed-end, downwardly looped, central curtain. The central curtain spans the dominant width of the header and loops from front to back. The center curtain joins with opposed pleated side curtains to compete the front seal. The downwardly looped central curtain has a series of staggered and overlapping weighted baffles proximal its front end. When a trailer backs into the dock, the trailer top engages one or more baffles, which ride up onto the top of the trailer. The elongated weighted baffles push rainwater off the trailer top as it backs into the bay, and remain in forced sealing engagement with the trailer top when it is parked to divert water off the trailer top and prevent the water from flowing or blowing into the bay.

Abstract: The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects.

Abstract: Polymers are prepared from a reaction mixture that contains a polyene compound, an epoxy resin, a mixture of a thiol curing agent and an amine curing agent, and a basic catalyst. The polyene compound has an average of at least two groups containing aliphatic carbon-carbon double bonds capable of reaction with a thiol group. At least one of said aliphatic carbon-carbon double bonds is separated from each other said aliphatic carbon-carbon double bond by an aliphatic spacer group having a weight of at least 500 atomic mass units. These polymers are typically phase-separated materials having good elongation and tensile properties.

Abstract: The invention provides seed and plants of tomato hybrid SV1240TC and the parent lines thereof. The invention thus relates to the plants, seeds and tissue cultures of tomato hybrid SV1240TC and the parent lines thereof, and to methods for producing a tomato plant produced by crossing such plants with themselves or with another tomato plant, such as a plant of another genotype. The invention further relates to seeds and plants produced by such crossing. The invention further relates to parts of such plants, including the fruit and gametes of such plants.

Abstract: The invention provides seed and plants of tomato hybrid DR4299TC and the parent lines thereof. The invention thus relates to the plants, seeds and tissue cultures of tomato hybrid DR4299TC and the parent lines thereof, and to methods for producing a tomato plant produced by crossing such plants with themselves or with another tomato plant, such as a plant of another genotype. The invention further relates to seeds and plants produced by such crossing. The invention further relates to parts of such plants, including the fruit and gametes of such plants.

Abstract: The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects.

Abstract: The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects.

Abstract: The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects.

Abstract: The invention provides seed and plants of tomato line FIR-15-2122. The invention thus relates to the plants, seeds and tissue cultures of tomato line FIR-15-2122, and to methods for producing a tomato plant produced by crossing such plants with themselves or with another tomato plant, such as a plant of another genotype. The invention further relates to seeds and plants produced by such crossing. The invention further relates to parts of such plants, including the fruit and gametes of such plants.